Homepage
Shaping the Future of HIV Research
amfAR interviewed Gladstone Institutes’ Dr. Melanie Ott about her work on HIV, hepatitis C, and other viruses, and the promise of new technologies.
HIV Science: Dynamic, Inspiring
amfAR’s Dr. Andrea Gramatica highlights three research projects presented at CROI with the potential to reshape our understanding of HIV cure strategies.
President Trump’s HIV Plan Is Too Valuable to Lose
amfAR analyses show states that implemented EHE would avert significantly more HIV treatment costs by 2030.
Explore more on Research, Policy and Advocacy, and TREAT Asia
Research Grants
amfAR utilizes formal requests for proposals to solicit grant applications for both targeted and general HIV/AIDS research. Proposals are then peer reviewed by the Scientific Advisory Committee on the basis of their relevance, scientific merit, and promise. To date, amfAR has awarded more than 3,800 grants to research teams worldwide.

Research Grants Awarded

Request for Proposals
REGISTRATION CLOSED
Letter of Intent due March 27, 2025, 3 PM EDT
Donate to amfAR: Fuel Lifesaving Research
Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.
Show the world that a cure isn’t just possible—it’s within reach.

New Edition of amfAR Magazine Out Now
This issue features an interview with UNAIDS Executive Director Winnie Byanyima and coverage of the most recent studies of the drug lenacapavir for PrEP and the latest probable case of an HIV cure. Plus updates on our research, public policy, and TREAT Asia programs, and much more.
Leading the Way to a Cure
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $900 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.